Pharma Journalist -

GT Biopharma focused on the development and commercialization of novel cancer immunotherapy products as well as central nervous system treatments asserted the appointment of Shawn M.…
Read More...

Influenza Vaccine is one of the best ways known to protect against the flu. However, because of the severity of this season, there have been questions raised about how well this year's…
Read More...

Arrowhead Pharmaceuticals sought approval from the New Zealand Medicines and Medical Devices Safety Authority (MEDSAFE) and from the local Ethics Committee to proceed with a…
Read More...

Clinical-stage biotechnology company, Aravive Biologics, Inc aiming to focus on development of treatments for Cancer and fibrotic diseases declared the commencement of  Phase 1 clinical…
Read More...

Arrowhead Pharmaceuticals seeks FDA's orphan drug designation to ARO-AAT.  Arrowhead’s second-generation investigational medicine for the treatment of a rare genetic liver disease…
Read More...

Banyan Biomarkers asserted that the U.S FDA has extended De Novo request for the commercialization of Banyan BTI Brain Trauma Indicator), an in vitro diagnostic blood test to aid in the…
Read More...

Celgene Corporation asserted that data from a randomized, placebo-controlled, multi-center, phase II clinical trial of apremilast in patients with active ulcerative colitis who had…
Read More...

Arterys Inc declared its fifth 510 (k) clearance for Arterys Oncology AI suite and is milestone indicative of the company's momentum in applying AI to further medical imaging accuracy…
Read More...

Applied artificial intelligence healthcare company, Viz.ai asserted that the US FDA has extended a De Novo request for the first-ever Computer -Aided Triage and Notification Platform to…
Read More...

DreaMed Diabetes asserted that it received CE Mark for the Advisor Pro decision-support platform for assisting healthcare professionals in the management of Type 1 diabetes. DreaMed…
Read More...